Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE

AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE

Standard Dose
50MG;4MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE is listed in Drugs@FDA under application 072135 (ANDA).

Marketing status: Discontinued Active ingredient AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE Form and strength TABLET;ORAL - 50MG;4MG Sponsor WATSON LABS Submission history Latest submission status date: 1996-04-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE is listed in Drugs@FDA under application 072135 (ANDA). Marketing status: Discontinued Active ingredient AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE Form and strength TABLET;ORAL - 50MG;4MG Sponsor WATSON LABS Submission history Latest submission status date: 1996-04-11 00:00:00. Submission type: SUPPL.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.